Public health & disease

From disease eradication efforts to advances in vaccination and maternal health, this archive tracks real progress in public health. Stories here focus on what’s working — policies, interventions, and research that are improving and extending lives around the world.

A healthcare worker administering a vaccine to a young child in Africa for an article about malaria vaccine rollout, for article on malaria vaccine rollout

Cameroon launches the world’s first routine malaria vaccine program

By / / Good News For Humankind

Malaria vaccine rollout reached a historic milestone in January 2024 when Cameroon became the first country to administer the RTS,S vaccine, also known as Mosquirix, as part of a routine national immunization program. More than 662,000 doses began reaching children across the country, targeting a disease responsible for 95% of global malaria deaths, most among children under five. The moment caps over 35 years of development and a successful WHO recommendation in 2021. With 19 additional African countries planning to follow, the rollout could eventually protect millions of children each year.

Manhattan skyline, for article on medical debt relief

New York City plans to wipe out $2 billion in medical debt for 500,000 residents

By / / Good News For Humankind

Medical debt relief is coming to New York City in a big way: a new program will wipe out more than $2 billion in unpaid medical bills for as many as 500,000 residents, no application required. The city is spending $18 million over three years and partnering with the nonprofit RIP Medical Debt, which buys debt portfolios for pennies on the dollar and simply cancels them. Eligible families will just receive a letter letting them know their balance is gone. With roughly 100 million Americans carrying some form of health care debt, this kind of municipal action offers a hopeful template — one that treats medical debt not as private misfortune, but as something cities can actually help fix.

Doctor holding vial of HPV vaccine, for article on HPV vaccination

No cervical cancer cases in HPV-vaccinated women in Scotland

By / / Good News For Humankind

Scotland’s HPV vaccine programme has produced a landmark result: zero cervical cancer cases among women who got the full vaccine series at age 12 or 13. Researchers reached that finding by tracking every woman in Scotland eligible for cervical screening since the programme launched in 2008, making it one of the most comprehensive studies of its kind. Pairing early vaccination with routine screening is what’s driving the result, and Public Health Scotland says the combination could turn cervical cancer into a rare disease. For countries where cervical cancer still kills tens of thousands of women each year, especially those without strong screening systems, this is powerful proof that prevention at scale really works.

Person receiving shot in the arm, for article on melanoma cancer vaccine

Cancer vaccine with minimal side effects nearing Phase 3 clinical trials

By / / Good News For Humankind

A personalized cancer vaccine is heading into Phase 3 trials after a remarkable Phase 2 result: nearly 95% of advanced melanoma patients who received only the vaccine were still alive three years later. What makes Dr. Thomas Wagner’s TLPO vaccine so striking isn’t just the survival numbers — it’s the gentleness. Patients report little more than a sore arm and mild fatigue, a world away from the dread of chemotherapy. The vaccine is made from each patient’s own tumor cells, teaching their immune system to recognize cancer as the threat it is. If the larger trial holds up, it could reshape how we think about treating cancer everywhere — not as something to endure, but something to outsmart.

Mosquito, for article on Cape Verde malaria-free

Cape Verde is declared malaria-free

By / / Good News For Humankind

Malaria-free Cape Verde just became the first sub-Saharan African country to earn that distinction in over 50 years, after going three straight years without a single locally transmitted case. The small island nation got there through patient, decades-long work: training surveillance officers to catch cases early, controlling mosquito populations, and offering free diagnosis and treatment to everyone — including travelers and migrants arriving from the mainland. That last choice mattered enormously, since imported cases are often what reignites local outbreaks. Cape Verde joins only Mauritius and Algeria in reaching this milestone on the continent, and its playbook offers something hopeful for the rest of Africa, where malaria still claims hundreds of thousands of lives each year.

Person happily holding a trans pride flag, for article on gender-affirming care

Maryland to cover unprecedented number of gender-affirming procedures in “groundbreaking” win

By / / Good News For Humankind

Maryland’s Medicaid program now covers gender-affirming care that reaches far beyond hormones and surgery, including voice therapy, fertility preservation, hair and scar removal, and a wide range of procedures. Under a law that took effect January 1, 2024, patients can only be denied a covered service if a clinician finds it would harm their individual health — never on the basis of identity. The bill grew directly out of conversations at Pride festivals and support groups across the state, shaped by trans Marylanders describing the barriers they faced. For residents like Renee Lau, who had been saving toward surgeries she couldn’t afford, the relief is immediate. As other states move to restrict trans healthcare, Maryland offers a hopeful template for how Medicaid can meet people where they are.

Person receiving nasal spray, for article on intranasal COVID-19 vaccine

Novel nasal COVID-19 vaccine offers longer, better immunity than jabs

By / / Good News For Humankind

A nasal COVID-19 vaccine developed at Duke-NUS Medical School in Singapore is showing real promise: in hamster studies, it produced more central memory T cells than standard injections, hinting at protection that could last considerably longer. By delivering the vaccine right where the virus enters the body, researchers also saw stronger antibody responses against newly emerging variants. The team has filed a patent that covers other respiratory pathogens too, opening doors for future flu and RSV vaccines. Human trials are still ahead, but for anyone weary of frequent boosters — especially elderly and immunocompromised people — a needle-free shot offering broader, longer protection could meaningfully reshape how the world lives alongside evolving respiratory viruses.

Cancer cells, for article on multi-cancer blood test

New protein test can detect 18 early stage cancers, scientists say

By / / Good News For Humankind

A new blood test can screen for 18 different cancers at once — covering every major organ in the body — using a single ordinary blood draw. Researchers at U.S. biotech firm Novelna found the test caught 93% of earliest-stage cancers in male samples and 84% in female samples, while also pinpointing which organ the cancer came from in more than 80% of cases. Instead of hunting for tumor DNA, the team analyzed proteins in blood plasma, picking up faint signals before a tumor does visible damage. Larger studies are still needed before it reaches clinics, but a cheap, accurate, broad screening tool would be a quiet revolution for global health — especially in places where late diagnosis is still the norm.

Tourists on Main Market Square in Krakow, for article on coal boiler replacement

Poland’s Clean Household Energy Initiative projected to prevent 20,000 deaths annually by 2030

By / / Good News For Humankind

Poland’s coal boiler swap could prevent more than 21,000 premature deaths every year by 2030, according to a new assessment from the European Clean Air Centre. The country is replacing half of its 2.7 million coal and wood-burning home furnaces with heat pumps and cleaner alternatives, at a clip of roughly 6,000 retrofits a week. What started as a grassroots push in Kraków a decade ago has grown into a €25 billion national programme, with heat pumps making up about half of all installations so far. Researchers are calling it a triple win: cleaner air, lower bills, and a third less carbon from homes. It’s a hopeful answer to anyone who says ambitious climate policy is too hard for ordinary people.

Molecule of the human hormone glucagon

Australian scientists regenerate diabetics’ damaged cells to produce insulin

By / / Good news links

For many years, research has focused on identifying novel therapies that stimulate beta-cell growth and function to restore insulin production in type 1 diabetics. Now, researchers at the Baker Heart and Diabetes Institute in Melbourne have brought us a step closer to making this a reality, regenerating damaged pancreatic cells so they can produce insulin and functionally respond to blood glucose levels. The novel therapeutic approach has the potential to become the first disease-modifying treatment for type 1 diabetes.